miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 5–20% of women of reproductive age. Interestingly, serum miR-124-3p and ANGPTL2 are differentially expressed in PCOS patients. Accordingly, this study set out to explore the clinical roles of serum miR-124-3p/ANGPTL2 in PCOS. First...
Saved in:
Main Authors: | Hongmei Dai, Fangting Liu, Jianshu Lu, Yan Yang, Pingping Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2022/2155018 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism
by: Lingye Fan, et al.
Published: (2021-01-01) -
Adrenocortical Production Is Associated with Higher Levels of Luteinizing Hormone in Nonobese Women with Polycystic Ovary Syndrome
by: Luciana Tock, et al.
Published: (2014-01-01) -
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
by: Carlos Moran, et al.
Published: (2012-01-01) -
Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01) -
Research of the Methylation Status of miR-124a Gene Promoter among Rheumatoid Arthritis Patients
by: Qiao Zhou, et al.
Published: (2013-01-01)